Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $621.37M.
ENTERPRISE VALUE (EV)
$621.37M
Solid Biosciences Inc.
Market Cap
$681.27M
Enterprise Value (EV)
$621.37M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Solid Biosciences Inc. (SLDB) | $681.27M | $621.37M |
| Verastem, Inc. (VSTM)vs › | $681.02M | $629.00M |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | $431.42M |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | $539.07M |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | $643.85M |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | $666.88M |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | $369.19M |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | $647.40M |
| Helus Pharma Inc. (HELP)vs › | $666.95M | $500.78M |
| Annexon, Inc. (ANNX)vs › | $660.29M | $485.67M |
Market Cap
$681.27M
Total Debt
$0.00
Cash
$59.90M
Enterprise Value
$621.37M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
